Your situation (severe hypercholesterolemia short-circuits the risk score) 10-yr PREVENT-ASCVD 5–<10% (intermediate)
risk-5-to-10No one has reached this rule yetStatin should be started; LDL-C <100, non-HDL-C <130 (30–49% reduction)
No clinician has signed off this rule yet. It reflects our reading of the guidelines cited below, which has not been independently checked.
Word for word, as generated for the example person below. Figures in the text are theirs.
Statin therapy should be started, aiming for LDL-C below 100 mg/dL (and non-HDL-C below 130) — which usually means cutting your LDL by 30-49%.
Expert guidelinesOfficial guidelines recommend it, based on trials plus expert judgment.
Your estimated 10-year PREVENT-ASCVD risk is 5.6%, in the guideline's "intermediate" band of 5% to just under 10%. Worth being precise about the goal: the LDL target of 70 belongs to the high-risk group at 10% and above, not to this band. Treatment is clearly recommended for you; the target is 100.
ACC/AHA (US)
Graded as at least a moderate-intensity statin; high-intensity is described as beneficial at the higher end of this band.
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia · Recommendation behind this rule · class and level read from the guideline tables on 2026-09-30
The LDL-C goal below 100 (non-HDL-C below 130)
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia · Graded separately within the same recommendation · class and level read from the guideline tables on 2026-09-30
ESC (Europe)
Pharmacological LDL-C lowering should be considered at moderate risk with LDL-C 100 mg/dL or higher. The ESC sorts risk with SCORE2, not the PREVENT equations used here, so the tiers line up only roughly.
2025 ESC/EAS focused update on dyslipidaemias · Recommendation tables · class and level read from the guideline tables on 2026-09-30
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia · Class 1 · Level A
“Intermediate risk” — an illustrative profile, not a real user.
Asked after: No known cardiovascular disease
Then asks: Coronary artery calcium (CAC) score? (further testing beyond basic labs)
Cited by the recommendations above.
For practising clinicians. Endorse it, propose a change, or dispute it. We verify every reviewer before a review is shown, and a review stays attached to the version of the rule you saw — if the rule changes, the page says so. You'll be asked to declare any relevant interests; they're shown with your review.
Log in or create an account to submit a review. An account is how we tie a review to a person we can verify.
Runs in lib/engine/lipidPathway.ts as risk-5-to-10.